Lactobacillus paracasei – LPC09 (DSM 24243)

    Urology blend | Kidney stones

    • Lactobacillus plantarum – LP01 (LMG P-21021)
    • Lactobacillus paracasei – LPC09 (DSM 24243)

    Characteristics

    FUNCTIONALITY
    1) LP01 2.5 billion + LPC09 1 billion

    FUNCTIONALITY
    Cystitis • Inhibition of E. coli • Metabolization of oxalates, prevention of kidney stones

    Scientific support

    Clinical study
    Vicariotto F. Effectiveness of An Association of a Cranberry Dry Extract, D-Mannose, and the 2 Microorganisms Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09 in Women Affected by Cystitis. Journal of Clin Gastroenterol 2014;48:S96-S101.

    In vitro studies
    a) Mogna L. et al. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains. J Clin Gastroenterol. 2012; 46 Suppl:S29-32.
    b) Mogna L. et al. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? J Clin Gastroenterol. 2014; 48 Suppl:S91-95.

    + Internal data on anti-inflammatory and anti-oxidant properties available upon request


    Urology blend | UTI

    • Lactobacillus plantarum – LP01 (LMG P-21021)
    • Lactobacillus paracasei – LPC09 (DSM 24243)

    Characteristics

    FUNCTIONALITY
    1) LP01 2.5 billion + LPC09 1 billion

    FUNCTIONALITY
    UTI • Inhibition of E. coli • Anti-inflammatory • Metabolization of oxalates, prevention of kidney stones

    Scientific support

    Clinical study
    Vicariotto F. Effectiveness of An Association of a Cranberry Dry Extract, D-Mannose, and the 2 Microorganisms Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09 in Women Affected by Cystitis. Journal of Clin Gastroenterol 2014;48:S96-S101.

    In vitro studies
    a) Mogna L. et al. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains. J Clin Gastroenterol. 2012; 46 Suppl:S29-32.
    b) Mogna L. et al. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? J Clin Gastroenterol. 2014; 48 Suppl:S91-95.

    + Internal data on anti-inflammatory and anti-oxidant properties available upon request


    Urology strain | Kidney stones

    Characteristics

    FUNCTIONALITY
    Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence

    Scientific support

    In vitro studies
    Mogna L. et al. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? (LPC09, LA02, LP01, LRE02, BR03, BL03) J Clin Gastroenterol. 2014; 48 Suppl:S91-95.

    + Internal data on anti-inflammatory and anti-oxidant properties available upon request on certain strains

    Clinical studies on-going on LP01+LPC09+Bb1 and other actives in prostate health